14
Participants
Start Date
October 23, 2018
Primary Completion Date
November 21, 2018
Study Completion Date
April 17, 2019
D-0502
D-0502 oral tablets
Covance Daytona Beach Clinical Research Unit, Daytona Beach
Lead Sponsor
InventisBio Co., Ltd
INDUSTRY